secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptorum Group Ltd (APM)
CIK:        0001734005
Form:       8-K/A
Filed at:   2026-08-21T21:17:44+00:00
Accession:  0001213900-26-092689
Event type: m_and_a
Sentiment:  negative
Materiality: 0.70
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Niki BioSolutions closes DiamiR merger; acquired firm posts FY2026 net loss and going-concern doubt
--------------------------------------------------------------------------------

- Merger closed July 20, 2026; DiamiR Biosciences became a wholly-owned subsidiary of Niki BioSolutions (formerly Aptorum Group).
- DiamiR FY2026 net loss of $659,936 vs $743,235 in FY2025; revenue grew to $190,355 from $631,729.
- Auditor cites significant working capital deficiency and needs to raise funds; going-concern doubt raised.
- As of May 31, 2026, DiamiR had cash of $112,690, current assets $345,250 and current liabilities $2,191,803.
- DiamiR's outstanding convertible notes are expected to convert to Niki common shares under the merger agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1734005/000121390026092689/0001213900-26-092689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1734005/000121390026092689/ea0301803-8ka1_nikibio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-092689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer